(Q33684772)

28 July 2017

1 reference

title

Endogenous salivary inhibitors of human immunodeficiency virus (English)

1 reference

28 July 2017

Shugars DC

1

1 reference

28 July 2017

Alexander AL

series ordinal

2

1 reference

28 July 2017

Fu K

series ordinal

3

1 reference

28 July 2017

Freel SA

series ordinal

4

1 reference

28 July 2017

1 June 1999

1 reference

28 July 2017

Archives of Oral Biology

1 reference

28 July 2017

44

1 reference

28 July 2017

6

1 reference

28 July 2017

445-453

1 reference

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

In vitro inhibition of HIV-1 infectivity by human salivas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Recovery of infectious HIV-1 from whole saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Inhibition of HIV-1 by modification of a host membrane protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Salivary and mucosal immune responses to HIV and its co-pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Saliva inhibits HIV-1 infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Tissue distribution of antileukoprotease and lysozyme in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Components of saliva inactivate human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Detection of proviral sequences in saliva of patients infected with human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Role of HIV-1 envelope V3 loop cleavage in cell tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

HIV antigens detected in gingival fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Submandibular salivary proteases: lack of a role in anti-HIV activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Human immunodeficiency virus type 1 and cytomegalovirus in saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Human Submandibular Saliva Aggregates HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

HIV infectivity is not augmented by treatment with trypsin, Factor Xa or human mast-cell tryptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

HIV recovery from saliva before and after dental treatment: inhibitors may have critical role in viral inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

The role of the V3 loop of gp120 in HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Human Submandibular Saliva Specifically Inhibits HIV Type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Defensins inhibit HIV replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

HIV excretion patterns and specific antibody responses in body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Does HIV cause salivary gland disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

The anti-HIV-1 activity associated with saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

The role of the oral environment in HIV-1 transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Cobalamin inhibition of HIV-1 integrase and integration of HIV-1 DNA into cellular DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Virucidal effects of glucose oxidase and peroxidase or their protein conjugates on human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Functions of the N-terminal domain of secretory leukoprotease inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

Oral HIV-I recovery in the presence of periodontal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Low level of cell-free virus detected at high frequency in saliva from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9969%2899%2900003-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-9969(99)00003-5

1 reference

28 July 2017

1 reference